scientifyRESEARCH
research funding database

RESEARCH FUNDING

2024 Hamoui Foundation/LUNGevity Clinical Research Award for RET-positive Lung Cancer (worldwide)

Share

Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange plus symbol appears between the two logos.
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The 2024 Hamoui Foundation/LUNGevity Clinical Research Award for RET-positive Lung Cancer supports high-impact research seeking to transform the future for people diagnosed with RET-positive lung cancer. Projects funded through this program are expected to have a direct impact on the outcomes of patients with advanced RET-positive lung cancer, but innovative proposals that address other unmet needs in the RET-positive lung cancer space are also invited for submission. Applicants must hold a doctoral degree and faculty appointment (or equivalent) with an academic institution, including research institutions that are not formally associated with a university, and have completed a postdoctoral training fellowship. Applicants may be based anywhere in the world.

The award provides up to 500,000 USD over 2 years (up to 10% indirect costs).

Letters of intent are due on February 9, 2024 and full invited applications are due on May 8, 2024.

Full application due:
May 8, 2024

non member

More related info for you

Register for free

Don´t have an account?

Start with our free trial to enjoy our 7 days of unlimited grant access and our premium features.

or, Choose a plan to subscribe to our premium membership.

Be the first to know

Sign-up for Personalized Grant alerts

Logo3

Sign-up for our
monthly research
funding newsletter

You can unsubscribe at any time.